eosinophiliamyalgia syndrome ems is characterized by subacute onset of myalgias and peripheral eosinophilia followed by chronic neuropathy and skin indurationan epidemic of ems in 1989 was linked to ltryptophan consumption originating from a single sourcefollowing the food and drug administration fda ban on the sale of ltryptophan the incidence of ems declined rapidlymoreover no new cases have been published since the fda ban was lifted in 2005we report the clinical histopathological and immunogenetic features of a new case of ltryptophanassociated ems along with evidence of activated transforming growth factor√ü and interleukin4 signaling in the lesional skin